Regulatory News
Thursday, July 14, 2016
BRIEF-Celgene International says European Commission approved Revlimid
* European Commission approved Revlimid for treatment of
adult patients with relapsed or refractory mantle cell lymphoma
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment